Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
A Practical Manual of Diabetic Retinopathy Management
The incidence of diabetes is increasing worldwide at an alarming rate, and diabetic retinopathy is one of the most significant complications of diabetes. Packed with outstanding retinal photos, the second edition of this one-stop clinical manual offers a comprehensive overview of the diagnosis, treatment and long–term management of patients with diabetic eye disease. Edited and authored by world-renowned experts from leading centres of excellence, A Practical Manual of Diabetic Retinopathy Management presents evidence-based guidance relevant for a global audience of health-care professionals, including diabetologists, ophthalmologists, retinal screeners, optometrists, ophthalmic nurses, GPs, and medical students.
Alzheimer’s Disease Research
This book highlights the key phases and central findings of Alzheimer’s Disease research since the introduction of the label ‘Alzheimer’s Disease’ in 1910. The author, Christian Behl, puts dementia research in the context of the respective zeitgeist and summarizes the paths that have led to the currently available Alzheimer’s drugs. As the reader is taken through the major developments in Alzheimer's Disease research, particularly over the past thirty years, Behl poses critical questions: Why are the exact causes of Alzheimer's Disease still in the dark, despite all the immense, worldwide research efforts in academia as well as in the pharmaceutical industry? Why has the majority o...
Biomarkers for Huntington's Disease
Huntington’s disease (HD) is a fatal, inherited, neurodegenerative disorder, characterized by chorea, motor instabilities, psychiatric manifestations and cognitive decline. Early genetic testing provides an opportunity for clinical interventions aimed at delaying onset and/or slowing progression of disease; however, current treatments for HD are limited, with only two FDA-approved drugs available to manage chorea. Encouragingly, however, several disease-modifying treatment approaches are in the therapeutic pipeline, with more than 200 clinical studies, and many more preclinical studies, in the works. Robust and reliable biomarkers are needed to predict disease onset, monitor disease progre...
